The King's Brief Lnterstitial Lung Disease Questionnaire | NCT07700004

Studies
The King's Brief Lnterstitial Lung Disease Questionnaire

NCT07700004

Sponsor

Pamukkale University

Status

Not yet recruiting

Last Update Posted

Jul 13, 2026Actual

Enrollment

45Estimated

Phase

Not provided

Conditions

Interstitial Lung Disease Due to Systemic Disease

Interventions

patient reported outcome measures

Countries

Turkey (Türkiye)

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Jul 2026

Overall Recruitment Status or Expanded Access Status

Not yet recruiting

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Jul 5, 2026Estimated

Primary Completion Date

Jan 15, 2027Estimated

Completion Date

May 15, 2027Estimated

First Submitted Date

Jul 7, 2026

First Submission Date that Met QC Criteria

Jul 7, 2026

First Posted Date

Jul 13, 2026Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Jul 7, 2026

Last Update Posted Date

Jul 13, 2026Actual

Oversight Module

Has Data Monitoring Committee (DMC)

Yes

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

The aim of this study is to examine the validity and reliability of the Turkish Validity and Reliability of The King's Brief Interstitial Lung Disease Questionnaire (K-BILD) in Individuals with Interstitial Lung Involvement Secondary to Rheumatological Diseases.

Detailed Description

Not provided

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Yes

Target Follow-Up Duration

1 Day

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

45Estimated

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Group I		Interstitial Lung Involvement Secondary to Rheumatological Diseases	Behavioral: patient reported outcome measures

Interventions

Name	Type	Description	Arm Group Labels	Other Names
patient reported outcome measures	Behavioral	King's Brief lnterstitial Lung Disease Questionnaire, Arthritis Impact Measurement Scales (AIMS2)-Short Form, Modified Medical Research Council (mMRC) Dyspnea Scale, Visual Analog Scale were evaluated.

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
King's Brief lnterstitial Lung Disease Questionnaire	It consists of 15 items and has a seven-point Likert scale.	10 minutes

Secondary Outcomes

Measure	Description	Time Frame
Arthritis Impact Measurement Scales (AIMS2)-Short Form	AIMS2-SF is a 26-item shortened form of AIMS2 and covers five components of quality of life.	15 minutes
Modified Medical Research Council (mMRC) Dyspnea Scale

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:-Having been diagnosed with interstitial lung disease by a rheumatologist,

Being 18 years of age or older,
Agreeing to participate in the study.

Exclusion Criteria:- Presence of a neurological disease

Presence of any orthopedic problem that affects functionality
History of any orthopedic surgery in the last year
Inability to speak or understand Turkish fluently
Presence of a psychiatric illness that affects cooperation
Heart failure that affects daily living activities
Being a cancer patient

Accepts Healthy Volunteers

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

Not provided

Standard Ages

AdultOlder Adult

Study Population

All patient-reported outcome measurements will be administered once, and King's Brief Interstitial Lung Disease Questionnaire will be administered twice, one week apart.

Sampling Method

Probability Sample

Contacts/Locations Module

Central Contacts

Name	Role	Phone	Extension	Email
Elif Gur Kabul	Contact	+902762212144		elifgur1988@hotmail.com

Overall Officials

Not provided

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Usak University		Uşak	Center	64200	Turkey (Türkiye)

IPD Sharing Statement Module

Plan to Share IPD

Description

Not provided

Types

Not provided

Time Frame

Not provided

Access Criteria

Not provided

URL

Not provided

Intervention Browse Module

MeSH Terms

ID	Term
D000071066	Patient Reported Outcome Measures

Ancestor Terms

ID	Term
D019538	Health Care Surveys
D011795	Surveys and Questionnaires
D003625	Data Collection
D004812	Epidemiologic Methods

Browse Leaves

Not provided

Browse Branches

Not provided